guggulsterones have been shown to raise LDL (bad)
the evidence for their effect on thyroid is controversial at best. its likely that any metabolic activity, anecdotally reported, is actually due to steroidal and farsenoid receptor activity.
Mol Pharmacol. 2004 Dec 16; [Epub ahead of print] Related Articles, Links
The Hypolipidemic Natural Product Guggulsterone is a Promiscuous Steroid Receptor Ligand.
Burris TP, Montrose C, Houck KA, Osborne HE, Bocchinfuso WP, Yaden BC, Cheng CC, Zink RW, Barr RJ, Hepler CD, Krishnan V, Bullock HA, Burris LL, Galvin RJ, Bramlett KS, Stayrook KR.
Lilly Research Laboratories.
Guggulsterone (GS) is the active substance in guggulipid, an extract of the guggul tree Commiphora mukul used to treat a variety of disorders in humans including dyslipidemia, obestity, and inflammation. The activity of GS has been suggested to be mediated by antagonism of the receptor for bile acids, the farnesoid X receptor (FXR). Here we demonstrate that both stereoisomers of the plant sterol, E- and Z-GS, bind to the steroid receptors at a much higher affinity than to FXR. Both stereoisomers bind to the mineralocorticoid receptor (MR) with a Ki of approximately 35 nM, which is greater than 100 times more potent than their affinity for FXR. Both E- and Z-GS also displayed high affinity for other steroid receptors including the androgen (AR), glucocorticoid (GR), and progesterone receptors (PR) with Kis ranging from 224 nM to 315 nM. In cell-based functional cotransfection assays, GSs behaved as antagonists of AR, GR, and MR, but as agonists of PR. Agonist activity was also demonstrated with ERalpha, however the potency was very low (EC50>5000 nM). In addition, GS displayed activity in functional assays in cell lines expressing endogenous AR, GR, ER, and PR. These data suggest that the variety of pharmacological effects exhibited by GS may be mediated by targeting several steroid receptors.